Monday, 6 June 2016

Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease

Volume 95, 1 May 2016, Pages 63-74

  (Article)

a  Dept of Pharmacology, School of Medicine, Western Sydney University, Campbelltown, NSW, Australia
b  National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, Australia
c  Molecular Medicine Research Group, Western Sydney University, Campbelltown, NSW, Australia 

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid plaques and neurofibrillary tangles, as well as microglial and astroglial activation, and, finally, leading to neuronal dysfunction and death. Current treatments for AD primarily focus on enhancement of cholinergic transmission. However, these treatments are only symptomatic, and no disease-modifying drug is available for the treatment of AD patients. This review will provide an overview of the antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective, and cognition-enhancing effects of a variety of nutraceuticals including curcumin, apigenin, docosahexaenoic acid, epigallocatechin gallate, α-lipoic acid and resveratrol and their potential for AD prevention and treatment. We suggest that therapeutic use of these compounds might lead to a safe strategy to delay the onset of AD or slow down its progression. The continuing investigation of the potential of these substances is necessary as they are promising compounds to yield a possible remedy for this pervasive disease. © 2015 Elsevier Ltd All rights reserved.

Author keywords

Alzheimer's disease; Apigenin; Curcumin; Fish oil; Green tea; Lipoic acid; Neuroinflammation
ISSN: 01970186 CODEN: NEUIDSource Type: Journal Original language: English
DOI: 10.1016/j.neuint.2015.10.011Document Type: Article
Publisher: Elsevier Ltd

  Münch, G.; Department of Pharmacology, School of Medicine, University of Western Sydney, Locked Bag 1797, Australia; email:g.muench@uws.edu.au
© Copyright 2016 Elsevier B.V., All rights reserved.